The outcomes of total knee arthroplasty following the incidental finding of tuberculosis and its treatment: A prospective study.


Journal

The Indian journal of tuberculosis
ISSN: 0019-5707
Titre abrégé: Indian J Tuberc
Pays: India
ID NLM: 0373027

Informations de publication

Date de publication:
Oct 2024
Historique:
received: 03 10 2023
revised: 09 11 2023
accepted: 27 12 2023
medline: 16 9 2024
pubmed: 16 9 2024
entrez: 15 9 2024
Statut: ppublish

Résumé

Extrapulmonary tuberculosis (EPTB) accounts for 16 % of tuberculosis cases globally, with knee joint tuberculosis more prevalent in underdeveloped nations. Total knee arthroplasty (TKA) is commonly used to treat tubercular arthritis of knee, however, there is a marked paucity of research on the outcomes after an incidental diagnosis. The aim of the study is to investigate the outcomes of total knee arthroplasty after an incidental diagnosis of tuberculosis and its management. A prospective-observational study was conducted in NCR-Delhi from May 2019 to June 2023, wherein 533 patients had synovial tissue abnormalities and 11 patients reported with positive histopathological examination (HPE) for knee tuberculosis. All the patients whose informed consent was obtained were put on a twelve-month standard treatment (2HRZE or S/10HR) according to World Health Organization (WHO) guidelines for extrapulmonary TB after TKA and were monitored for the outcome of treatment, any postoperative complication, or implant failure. The mean age of the patients was 63 ± 13 years and 72.7 % of patients were female. The mean hemoglobin, Body Mass Index (BMI), and Erythrocyte Sedimentation Rate (ESR) values were 10.29 ± 1.36 mg/dl, 29.78 ± 6.1 kg/m We concluded from this study that any abnormalities in ESR, CRP level prior to, and bone tissue or synovial tissue during operative procedure should be considered for articular tuberculosis and managed according to guidelines. This will make replacement procedures more sustainable and effective by lowering the risk of post-operative infection or implant-related complications and improving patients' quality of life.

Identifiants

pubmed: 39278680
pii: S0019-5707(23)00228-7
doi: 10.1016/j.ijtb.2023.12.011
pii:
doi:

Substances chimiques

Antitubercular Agents 0

Types de publication

Journal Article Observational Study Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

460-464

Informations de copyright

Copyright © 2023 Tuberculosis Association of India. Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Sujoy Bhattacharjee (S)

Sarvodaya Hospital Research Centre Sector 8, Sarvodaya Hospital Sector 19, Faridabad, Haryana, India. Electronic address: propesi2020@gmail.com.

Avijeet Prasad (A)

Department of Orthopaedics. Sarvodaya Hospital Sector -8, Faridabad, Haryana, India. Electronic address: dravijeet@gmail.com.

Akhil Ahlawat (A)

Department of Orthopaedics. Sarvodaya Hospital Sector -8, Faridabad, Haryana, India. Electronic address: Ahlawat.Akhil.1991@gmail.com.

Pavan R B (P)

Department of Orthopaedics. Sarvodaya Hospital Sector -8, Faridabad, Haryana, India. Electronic address: drpavanfnb@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH